Publisher's Synopsis
The ability to find disease is limited by the tools we have available to find that disease. Many tests are plagued by errors. The inability to find the problem when present - aka sensitivity. The inability to correctly exclude a problem when it isn't present - aka specificity. Nuclear imaging provides the ability to see what's happening inside the body without having to invasively remove parts of the body to look for problems. The current approach however is limited by the errors made when doctors look at images to decide if you do or don't have a disease. These problems have lead to a recognition that human error, guessing at whether something is present or not, and more importantly if problems like heart disease, cancer, and even CoVid-19, need treatment or are responding to treatment, has lead to the quest for a method that can accurately measure what is happening inside the body.The Fleming Method for Tissue and Vascular Differentiation and Metabolism (FMTVDM) is the first patented method for doing so. With FMTVDM the extent of a problem can be measured and with that measurement, the effect of treatment can be measured, allowing physicians to decide if you should continue with the same treatment or change and try a different approach.In this book, the details of FMTVDM for heart disease and cancer are discussed. This book provides a useful tool for understanding heart disease and cancer and when correctly used for SARS-CoV-2 (CoVid-19). This book does NOT entitle the reader to conduct FMTVDM tests. That requires a license (patent # 9566037) which can only legally be obtained from the author.
